Standardizing wound treatment procedures for advanced technologies

Journal of the American Podiatric Medical Association

Volumn 92, Issue 1, 2002, Pages 7-11

  Mulder, Gerit D ^a  

^a UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED GROWTH FACTOR;

DRUG EFFECT; HUMAN; INJURY; PHYSIOLOGY; PODIATRY; PRACTICE GUIDELINE; REVIEW; SENSITIVITY AND SPECIFICITY; STANDARD; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; WOUND HEALING;

ADMINISTRATION, TOPICAL; HUMANS; PLATELET-DERIVED GROWTH FACTOR; PODIATRY; PRACTICE GUIDELINES; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; WOUND HEALING; WOUNDS AND INJURIES;

EID: 0036356611     PISSN: 87507315     EISSN: None     Source Type: Journal    
DOI: 10.7547/87507315-92-1-7     Document Type: Review

References (6)

1. AMERICAN DIABETES ASSOCIATION: Consensus Development Conference on Diabetic Foot Wound Care. Diabetes Care 22: 1354, 1999.
2. Drug treatment protocols: management of foot ulcers in patients with diabetes. J Am Pharm Assoc (Wash) 40: 467, 2000.
3. BERGSTROM N, BENNETT MA, CARLSON CE, ET AL: Clinical Practice Guideline Number 15: Treatment of Pressure Ulcers. AHCPR publication 95-0652. US Dept of Health and Human Services, Agency for Health Care Policy and Research, Rockville, MD, 1994.
4. Dorland's Illustrated Medical Dictionary, 28th Ed, WB Saunders, Philadelphia, 1994.
5. WOUND CONSULTANTS INC: WCI Manual, Denver, 1998.
6. GOEBEL RH, GOEBEL MR: Clinical practice guidelines for pressure ulcer prevention can prevent malpractice lawsuits in older patients. J Wound Ostomy Continence Nurs. 26: 175, 1999.